NCT01934010View on ClinicalTrials.gov

AM-101 in the Treatment of Post-Acute Tinnitus 1

PHASE3CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Tinnitus
Interventions
DRUG

AM-101

AM-101 gel for intratympanic injection

Trial Locations (1)

45227

Medpace, Cincinnati

Sponsors
All Listed Sponsors
lead

Auris Medical, Inc.

INDUSTRY

NCT01934010 - AM-101 in the Treatment of Post-Acute Tinnitus 1 | Biotech Hunter | Biotech Hunter